Navegando por Palavras-chave "Bacterial pneumonia"

Agora exibindo 1 - 1 de 1
  • Imagem de Miniatura
    Item
    Acesso aberto (Open Access)
    Perfil de sensibilidade a antimicrobianos de bactérias isoladas do trato respiratório baixo de pacientes com pneumonia internados em hospitais brasileiros: resultados do Programa SENTRY, 1997 e 1998
    (Sociedade Brasileira de Pneumologia e Tisiologia, 2001-03-01) Sader, Helio Silva [UNIFESP]; Mendes, Rodrigo Elisandro [UNIFESP]; Gales, Ana Cristina [UNIFESP]; Jones, Ronald N.; Pfaller, Michael A.; Zoccoli, Cassia; Sampaio, Jorge; Universidade Federal de São Paulo (UNIFESP); Universidade de Iowa Faculdade de Medicina Departmento de Patologia; Laboratório Santa Luzia; Laboratório Lâmina
    Background: Nosocomial pneumonia is the most common fatal nosocomial infection with attributable mortality rates ranging from 30 to 60% and a rapid initiation of optimal antimicrobial therapy is important to obtain treatment success. SENTRY is a comprehensive antimicrobial surveillance study involving a great number of medical centers distributed worldwide. Objective: To evaluate the antimicrobial susceptibility of bacterial isolates collected from the lower respiratory tract of inpatients with pneumonia. Material & methods: The authors report the antimicrobial susceptibility of 525 isolates collected in 11 Brazilian hospitals, as part of the SENTRY program. The isolates were tested for susceptibility by broth micro-dilution against a large number of drugs. Results: The five most frequently isolated species were (n/%): Pseudomonas aeruginosa (158/30.1%), Staphylococcus aureus (103/19.6%), Acinetobacter spp. (68/13.0%), Klebsiella spp. (50/9.5%), and Enterobacter spp. (44/8.4%). These five species represented more than 80% of all isolates. P. aeruginosa demonstrated high rates of resistance to most antimicrobial agents tested. The highest susceptibility rates were shown by piperacillin/tazobactam (71.5%) and meropenem (69.0%). Acinetobacter spp. also showed very high rates of resistance. The most active compounds against this species were imipenem and meropenem (80.9% susceptibility) followed by tetracycline (63.2% susceptibility). Cephalosporin susceptibilities among Klebsiella spp were very low and 36.0% of isolates were considered ESBL producers based on increased MICs, > 2 mug/mL) to ceftriaxone or ceftazidime or aztreonam. Ceftriaxone was active against only 56.8% of Enterobacter spp. isolates (MIC50 1 mug/mL), while cefepime was active against 88.6% of these isolates (MIC, < 0.12 mg/mL). Oxacillin-resistance was detected in 43.7% of S. aureus isolates. The most active drugs against this species were vancomycin, teicoplanin, quinupristin/dalfopristin, and linezolid. Conclusion: The results of this study demonstrated a higher prevalence of Acinetobacter spp. and higher resistance rates among Gram-negative rods when compared with results from North American and European studies.